| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $6.52B | +9.4% |
| Gross profit | $5.84B | — |
| Operating income | $2.95B | — |
| Net income | $1.98B | +6.2% |
| Gross margin | 89.6% | Net margin 30.4% |
| Segment | Revenue | Share |
|---|---|---|
| International Operated Markets | $3.33B | 51.0% |
| USMarket | $2.58B | 39.6% |
| International Developmental Licensed Marketsand Corporate | $0.61B | 9.4% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.68B | 10.4% |
| SG&A | $0.76B | 11.6% |
| Tax & other | $0.97B | 14.9% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
MCK ・ MDT ・ MRK ・ META ・ MET ・ MTD ・ MGM ・ MCHP ・ MU ・ MSFT ・ MAA ・ MRNA
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies